Search results for "Neurosciences"

showing 10 items of 844 documents

Lack of Accredited Clinical Training in Movement Disorders in Europe, Egypt, and Tunisia.

2020

BACKGROUND: Little information is available on the official postgraduate and subspecialty training programs in movement disorders (MD) in Europe and North Africa.OBJECTIVE: To survey the accessible MD clinical training in these regions.METHODS: We designed a survey on clinical training in MD in different medical fields, at postgraduate and specialized levels. We assessed the characteristics of the participants and the facilities for MD care in their respective countries. We examined whether there are structured, or even accredited postgraduate, or subspecialty MD training programs in neurology, neurosurgery, internal medicine, geriatrics, neuroradiology, neuropediatrics, and general practic…

medicine.medical_specialtyMovement disordersTunisiaParkinson's diseaseeducationNorth africaCertificationSubspecialtyDIAGNOSIS3124 Neurology and psychiatryAccreditation03 medical and health sciencesCellular and Molecular Neuroscience0302 clinical medicinemedicineHumans030212 general & internal medicineCurriculumAccreditationGeriatricsMedical educationeducationMovement Disorders4. Education3112 Neurosciences3. Good healthEuropeNeurologyEducation Medical GraduateClinical trainingHealth Care SurveysSUBSPECIALIZATIONEgyptNeurology (clinical)Curriculummedicine.symptomPsychology030217 neurology & neurosurgeryJournal of Parkinson's disease
researchProduct

COVID-19 and Alzheimer’s Disease

2021

The Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) is a neurotropic virus with a high neuroinvasive potential. Indeed, more than one-third of patients develop neurological symptoms, including confusion, headache, and hypogeusia/ageusia. However, long-term neurological consequences have received little interest compared to respiratory, cardiovascular, and renal manifestations. Several mechanisms have been proposed to explain the potential SARS-CoV-2 neurological injury that could lead to the development of neurodegenerative diseases, including Alzheimer’s Disease (AD). A mutualistic relationship between AD and COVID-19 seems to exist. On the one hand, COVID-19 patients seem to …

medicine.medical_specialtyNeurological injuryCoronavirus disease 2019 (COVID-19)Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)neuroinflammation.DiseaseReviewneuroinflammationlcsh:RC321-57103 medical and health sciences0302 clinical medicineMedicineIntensive care medicinelcsh:Neurosciences. Biological psychiatry. NeuropsychiatryNeuroinflammation030304 developmental biologyNeurotropic virus0303 health sciencesneurodegenerative niseasebusiness.industrySARS-CoV-2General NeuroscienceHypogeusianervous systembiomarkersADAgeusiabiomarkermedicine.symptombusiness030217 neurology & neurosurgeryBrain Sciences
researchProduct

Economic Evaluation in Neurological Physiotherapy: A Systematic Review

2021

This systematic review was carried out to compile and assess original studies that included economic evaluations of neurological physiotherapy interventions. A thorough search of PubMED, Cochrane and Embase was developed using keywords such as health economics, neurological physiotherapy and cost analysis, and studies published during the last six-year term were selected. A total of 3124 studies were analyzed, and 43 were eligible for inclusion. Among the studies analyzed, 48.8% were interventions for stroke patients, and 13.9% were focused on Parkinson’s disease. In terms of the countries involved, 46.5% of the studies included were developed in the UK, and 13.9% were from the USA. The eco…

medicine.medical_specialtyNeurologyPsychological interventionDiseaseReviewmedicallcsh:RC321-57103 medical and health sciences0302 clinical medicineMedicine030212 general & internal medicinelcsh:Neurosciences. Biological psychiatry. NeuropsychiatryHealth economicsphysical therapy modalitiesNeurological PhysiotherapyCost–benefit analysisbusiness.industryGeneral Neurosciencecost-benefit analysisneurologyeconomicsEconomic evaluationCost analysisPhysical therapybusiness030217 neurology & neurosurgeryBrain Sciences
researchProduct

Effectiveness and safety of Nintendo Wii Fit PlusTM training in children with migraine without aura a preliminary study

2013

Maria Esposito,1 Maria Ruberto,2 Francesca Gimigliano,1,2 Rosa Marotta,3 Beatrice Gallai,4 Lucia Parisi,5 Serena Marianna Lavano,3 Michele Roccella,5 Marco Carotenuto11Center for Childhood Headache, Child and Adolescent Neuropsychiatry Clinic, Department of Mental Health, Physical and Preventive Medicine, 2Department of Odonto-Stomathologic Disciplines, Pathology – Orthopedic Sciences, Second University of Naples, Naples, Italy; 3Department of Psychiatry, “Magna Graecia” University of Catanzaro, Catanzaro, Italy; 4Unit of Child and Adolescent Neuropsychiatry, University of Perugia, Perugia, Italy; 5Child Neuropsychiatry, Department of Psychology, University of …

medicine.medical_specialtyNeuropsychiatric Disease and TreatmentAuraNeurosciences. Biological psychiatry. NeuropsychiatryPediatric migrainecomputer.software_genreMovement assessmentChildhood rehabilitationMedicineRC346-429Biological PsychiatryBalance (ability)Original ResearchIntelligence quotientbusiness.industryNintendo Wii Fit Plus™medicine.diseaseSettore MED/39 - Neuropsichiatria InfantileMotor coordinationPsychiatry and Mental healthMigraineMigraine without auraPhysical therapyAbsenteeismPopulation studyNeurology. Diseases of the nervous systemData miningbusinesscomputerRC321-571
researchProduct

Attachment styles in children affected by migraine without aura

2013

Maria Esposito,1 Lucia Parisi,2 Beatrice Gallai,3 Rosa Marotta,4 Anna Di Dona,1 Serena Marianna Lavano,2 Michele Roccella,4 Marco Carotenuto11Center for Childhood Headache, Clinic of Child and Adolescent Neuropsychiatry, Department of Mental Health, Physical and Preventive Medicine, Second University of Naples, Naples, Italy; 2Child Neuropsychiatry, Department of Psychology, University of Palermo, Palermo, Italy; 3Unit of Child and Adolescent Neuropsychiatry, University of Perugia, Perugia, Italy; 4Department of Psychiatry, The Magna Graecia University of Catanzaro, Catanzaro, ItalyBackground: In recent years, great attention has been given to the presence of psychological problems and psyc…

medicine.medical_specialtyNeuropsychiatric Disease and TreatmentAuraVisual analogue scaleNeurosciences. Biological psychiatry. NeuropsychiatrySpearman's rank correlation coefficientCorrelationchildrenmedicineAttachment theoryPain perceptionPsychiatryRC346-429Separation Anxiety TestBiological PsychiatryOriginal Researchbusiness.industrymigraine without aura; children; attachment stylemedicine.diseaseSettore MED/39 - Neuropsichiatria InfantilePsychiatry and Mental healthMigrainemigraine without auraPopulation studyNeurology. Diseases of the nervous systemattachment stylebusinessClinical psychologyRC321-571
researchProduct

Self-concept evaluation and migraine without aura in childhood

2013

Maria Esposito,1 Beatrice Gallai,2 Lucia Parisi,3 Laura Castaldo,1 Rosa Marotta,4 Serena Marianna Lavano,4 Giovanni Mazzotta,5 Michele Roccella,3 Marco Carotenuto11Center for Childhood Headache, Clinic of Child and Adolescent Neuropsychiatry, Department of Mental Health, Physical and Preventive Medicine, Second University of Naples, Naples, Italy; 2Unit of Child and Adolescent Neuropsychiatry, University of Perugia, Perugia, Italy; 3Child Neuropsychiatry, Department of Psychology, University of Palermo, Palermo, Italy; 4Department of Psychiatry, "Magna Graecia" University of Catanzaro, Catanzaro, Italy; 5Unit of Child and Adolescent Neuropsychiatry, AUSL Umbria 2, Terni, I…

medicine.medical_specialtyNeuropsychiatric Disease and TreatmentVisual analogue scaleAuramedia_common.quotation_subjectPopulationNeurosciences. Biological psychiatry. NeuropsychiatryAngerNeuropsychiatryInternal medicineSelf-esteemmedicineeducationPsychiatryRC346-429ChildrenBiological PsychiatryOriginal Researchmedia_commonchildren self-esteem MSCSeducation.field_of_studybusiness.industryMSCSmedicine.diseaseSettore MED/39 - Neuropsichiatria InfantilePsychiatry and Mental healthMigraineAnxietyPopulation studyNeurology. Diseases of the nervous systemmedicine.symptombusinessRC321-571Neuropsychiatric Disease and Treatment
researchProduct

Acupressure therapy for insomnia in adolescents: a polysomnographic study

2013

Marco Carotenuto,1 Beatrice Gallai,2 Lucia Parisi,3 Michele Roccella,3 Maria Esposito11Sleep Clinic for Developmental Age, Clinic of Child and Adolescent Neuropsychiatry, Second University of Naples, Naples, 2Unit of Child and Adolescent Neuropsychiatry, University of Perugia, Perugia, 3Child Neuropsychiatry, Department of Psychology, University of Palermo, Palermo, ItalyBackground: The purpose of this study was to assess the efficacy of acupressure therapy in a sample of adolescents with insomnia using a standard polysomnographic evaluation.Methods: For this study, 25 adolescents affected by psychophysiological insomnia (mean age 15.04 ± 1.18 years, 12 boys) were enrolled. A dev…

medicine.medical_specialtyNeuropsychiatric Disease and TreatmentinsomniaAcupressureNeurosciences. Biological psychiatry. NeuropsychiatryPolysomnographyNeuropsychiatrypolysomnographyacupressuremedicineInsomniaAcupressure TherapyPsychiatryRC346-429Biological PsychiatryOriginal ResearchSlow-wave sleepmedicine.diagnostic_testbusiness.industryinsomnia; adolescence; acupressureSettore MED/39 - Neuropsichiatria InfantilePsychiatry and Mental healthPhysical therapyadolescenceSleep onset latencyNeurology. Diseases of the nervous systemmedicine.symptomSleep onsetbusinessRC321-571
researchProduct

Towards a framework for treatment effectiveness in schizophrenia

2014

Georg Juckel,1 Andrea de Bartolomeis,2 Philip Gorwood,3 Sergey Mosolov,4 Luca Pani,5 Alessandro Rossi,6 Julio Sanjuan7 1Department of Psychiatry, LWL-University Hospital, Ruhr-University Bochum, Bochum, Germany; 2Laboratory of Molecular Psychiatry and Unit of Treatment Resistant Psychosis, University School of Medicine of Naples Federico II, Napoli, Italy; 3Groupe Hospitalier Sainte-Anne (CMME), Paris-Descartes University, Paris, France; 4Moscow Research Institute of Psychiatry, Moscow, Russia; 5Institute of Translational Pharmacology, Italian National Research Council, Rome, Italy; 6Università de L’Aquila, L’Aquila, Italy; 7Clinic Hospital, Spanish Mental Hea…

medicine.medical_specialtyNeuropsychiatric Disease and Treatmentmedicine.medical_treatmentAlternative medicineSatisfactionNeurosciences. Biological psychiatry. NeuropsychiatryDiseaseAntipsychoticAssessment scaleExtrapyramidal symptomsmedicineFunctioningCognitive skillAntipsychoticPsychiatryRC346-429Biological PsychiatryDisease burdenOriginal Researchassessment scalesbusiness.industryMental illneMental illnessmedicine.diseasemental illnessAntipsychotic; Assessment scales; Functioning; Mental illness; SatisfactionPsychiatry and Mental HealthMental illnessSchizophreniaNeurology. Diseases of the nervous systemmedicine.symptombusinessAssessment scalesRC321-571Neuropsychiatric Disease and Treatment
researchProduct

Guanfacine extended release for children and adolescents with attention-deficit/hyperactivity disorder: Efficacy following prior methylphenidate trea…

2016

Guanfacine extended release (GXR) and atomoxetine (ATX) are nonstimulant treatments for attention-deficit/hyperactivity disorder (ADHD). As nonstimulant treatments are often used after stimulants in ADHD, GXR was assessed relative to prior stimulant treatment in a randomized controlled trial (RCT), in which ATX was included as a reference arm, and in the open-label phase of a randomized-withdrawal study (RWS). Participants were 6–17 years old with ADHD Rating Scale version IV (ADHD-RS-IV) scores ≥32 and Clinical Global Impressions – Severity scores ≥4. RCT participants received dose-optimized GXR (1–7 mg/day), ATX (10–100 mg/day), or placebo for 10–13 weeks. RWS participants received dose-o…

medicine.medical_specialtyNeuropsychiatric Disease and Treatmentmedicine.medical_treatmenteffectivenessmethylphenidateNeurosciences. Biological psychiatry. NeuropsychiatryPlacebolaw.invention03 medical and health sciences0302 clinical medicineRandomized controlled trialRating scalelawInternal medicinemental disordersmedicineAttention deficit hyperactivity disorderADHD0501 psychology and cognitive sciencesPsychiatryRC346-429child and adolescentguanfacineOriginal Researchbusiness.industryMethylphenidate05 social sciencesAtomoxetinetrialmedicine.disease030227 psychiatryGuanfacineinadequate respondersStimulantNeurology. Diseases of the nervous systembusinessGXRatomoxetine050104 developmental & child psychologymedicine.drugRC321-571
researchProduct

Prevalence of eating disorders and eating attacks in narcolepsy

2008

Norbert Dahmen, Julia Becht, Alice Engel, Monika Thommes, Peter TonnPsychiatry Department, University of Mainz, GermanyAbstract: Narcoleptic patients suffer frequently from obesity and type II diabetes. Most patients show a deficit in the energy balance regulating orexinergic system. Nevertheless, it is not known, why narcoleptic patients tend to be obese. We examined 116 narcoleptic patients and 80 controls with the structured interview for anorectic and bulimic eating disorders (SIAB) to test the hypothesis that typical or atypical eating attacks or eating disorders may be more frequent in narcoleptic patients. No difference in the current prevalence of eating disorders bulimia nervosa, b…

medicine.medical_specialtyNeuropsychiatric Disease and TreatmentnarcolepsyNeurosciences. Biological psychiatry. NeuropsychiatryAnorexiaAnorexia nervosaeating attackBinge-eating disordermental disordersMedicinePsychiatryRC346-429Biological PsychiatryOriginal Researchbusiness.industryBulimia nervosadigestive oral and skin physiologymedicine.diseaseObesityPsychiatry and Mental healthEating disordersbulimiaanorexiaeating disorderAnorecticSIABNeurology. Diseases of the nervous systemmedicine.symptombusinessNarcolepsyRC321-571Neuropsychiatric Disease and Treatment
researchProduct